Lewy bodies And NotCharles H. Adler
List of bibliographic references
Number of relevant bibliographic references: 23.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000143 | René Hernández- Vargas [Mexique] ; Luis Fonseca- Ornelas [Mexique] ; Ignacio L Pez- González [Mexique] ; Juan Riesgo- Escovar [Mexique] ; Mario Zurita [Mexique] ; Enrique Reynaud [Mexique] | Synphilin suppresses α‐synuclein neurotoxicity in a Parkinson's disease Drosophila model |
| 000168 | R. Fekete [États-Unis] ; Joseph Jankovic [États-Unis] | Revisiting the relationship between essential tremor and Parkinson's disease |
| 000253 | Glenda Halliday [Australie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Matthew Stern [États-Unis] | Milestones in Parkinson's disease—Clinical and pathologic features |
| 000274 | S. Sharma [Royaume-Uni] ; R. Bandopadhyay ; T. Lashley ; A. E. M. Renton [Royaume-Uni] ; A. E. Kingsbury ; R. Kumaran ; C. Kallis ; C. Vilari O-Güell ; S. S. O'Sullivan ; Andrew Lees (neurologue) [Royaume-Uni] ; T. Revesz ; N. W. Wood ; J. L. Holton | LRRK2 expression in idiopathic and G2019S positive Parkinson's disease subjects: a morphological and quantitative study |
| 000512 | Glenda Margaret Halliday [Australie] ; Heather Mccann [Australie] | The progression of pathology in Parkinson's disease |
| 000931 | Thibaud Lebouvier [France] ; Tanguy Chaumette [France] ; Sébastien Paillusson [France] ; Charles Duyckaerts [France] ; Stanislas Bruley Des Varannes [France] ; Michel Neunlist [France] ; Pascal Derkinderen [France] | The second brain and Parkinson’s disease |
| 000C47 | M. E. Kalaitzakis [Royaume-Uni] ; M. B. Graeber [Royaume-Uni] ; S. M. Gentleman [Royaume-Uni] ; R. K. B. Pearce [Royaume-Uni] | The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of α‐synuclein staging |
| 000C78 | Carola Schiesling ; Nicole Kieper ; Kay Seidel [Allemagne] ; Rejko Krüger | Review: Familial Parkinson's disease – genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease |
| 000D36 | Maria G. Cersosimo [Argentine] ; Eduardo E. Benarroch [États-Unis] | Neural control of the gastrointestinal tract: Implications for Parkinson disease |
| 000E63 | K. Wada-Isoe [Japon] ; K. Ohta [Japon] ; K. Imamura [Japon] ; M. Kitayama [Japon] ; T. Nomura [Japon] ; K. Yasui [Japon] ; K. Nakaso [Japon] ; K. Nakashima [Japon] | Assessment of hallucinations in Parkinson’s disease using a novel scale |
| 000F81 | Elan D. Louis [États-Unis] ; Steven J. Frucht [États-Unis] | Prevalence of essential tremor in patients with Parkinson's disease vs. Parkinson‐plus syndromes |
| 001158 | A. Bloch [Suisse] ; A. Probst [Suisse] ; H. Bissig [Suisse] ; H. Adams [Suisse] ; M. Tolnay [Suisse] | α‐Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects |
| 001354 | G. Webster Ross [États-Unis] ; Robert D. Abbott [États-Unis] ; Helen Petrovitch [États-Unis] ; Caroline M. Tanner [États-Unis] ; Daron G. Davis [États-Unis] ; James Nelson [États-Unis] ; William R. Markesbery [États-Unis] ; John Hardman [États-Unis] ; Kamal Masaki [États-Unis] ; Lenore Launer [États-Unis] ; Lon R. White [États-Unis] | Association of olfactory dysfunction with incidental Lewy bodies |
| 001437 | Katsumi Tsuchiya [Japon] ; Hisao Tajima [Japon] ; Toyoyasu Kuwae [Japon] ; Takao Takeshima [Japon] ; Toshiya Nakano [Japon] ; Masaharu Tanaka [Japon] ; Katsuyoshi Sunaga [Japon] ; Yoko Fukuhara [Japon] ; Kenji Nakashima [Japon] ; Eisaku Ohama [Japon] ; Hideki Mochizuki [Japon] ; Yoshikuni Mizuno [Japon] ; Nobuo Katsube [Japon] ; Ryoichi Ishitani [Japon] | Pro‐apoptotic protein glyceraldehyde‐3‐phosphate dehydrogenase promotes the formation of Lewy body‐like inclusions |
| 001461 | Naheed L. Khan ; Shushant Jain ; John M. Lynch ; Nicola Pavese ; Patrick Abou-Sleiman ; Janice L. Holton ; Daniel G. Healy ; William P. Gilks ; Mary G. Sweeney ; Milan Ganguly ; Vaneesha Gibbons ; Sonia Gandhi ; Jenny Vaughan ; Louise H. Eunson ; Regina Katzenschlager ; Juliet Gayton ; Graham Lennox ; Tamas Revesz ; David Nicholl [Royaume-Uni] ; Kailash P. Bhatia ; Niall Quinn ; David Brooks ; Andrew Lees (neurologue) [Royaume-Uni] ; Mary B. Davis ; Paola Piccini ; Andrew B. Singleton [États-Unis] ; Nicholas W. Wood | Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data |
| 001880 | David A. Grimes [Canada] ; J. David Grimes [Canada] ; Lem Racacho [Canada] ; Kylie A. Scoggan [Canada] ; Fabin Han [Canada] ; Betty Anne Schwarz [Canada] ; John Woulfe [Canada] ; Dennise Bulman [Canada] | Large French‐Canadian family with Lewy body parkinsonism: Exclusion of known loci |
| 001989 | Yasushi Arai [Japon] ; Mineo Yamazaki [Japon] ; Osamu Mori [Japon] ; Hiromi Muramatsu [Japon] ; Goro Asano [Japon] ; Yasuo Katayama [Japon] | α-Synuclein-positive structures in cases with sporadic Alzheimer’s disease: morphology and its relationship to tau aggregation |
| 001B11 | Subramianian Rajagopalan [États-Unis] ; Julie K. Andersen [États-Unis] | Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson's disease? |
| 001C47 | G. Münch [Allemagne] ; H. J. Lüth [Allemagne] ; A. Wong [Allemagne] ; Th. Arendt [Allemagne] ; E. Hirsch [France] ; R. Ravid [Pays-Bas] ; P. Riederer [Allemagne] | Crosslinking of α-synuclein by advanced glycation endproducts — an early pathophysiological step in Lewy body formation? |
| 002023 | Lutz M. Drach [Allemagne] ; Hans E. E. Steinmetz [Allemagne] ; Stefanie Wach [Allemagne] ; Jürgen Bohl [Allemagne] | HIGH PROPORTION OF DEMENTIA WITH LEWY BODIES IN THE POSTMORTEMS OF A MENTAL HOSPITAL IN GERMANY |
| 002358 | John Hardy [États-Unis] | Apolipoprotein E in the genetics and epidemiology of Alzheimer's disease |
| 002692 | J. O. Rinne [Finlande] | Nigral degeneration in Parkinson's disease in relation to clinical features |
| 002770 | Robert H. Perry ; Dorothy Irving ; Bernard E. Tomlinson | Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei |
| This area was generated with Dilib version V0.6.23. |  |